Maju Mathews, MD

Effect of Benzodiazepines on Esketamine Nasal Spray for Treating Patients With Major Depressive Disorder With Active Suicidal Ideation and Intent

Aim: To examine potential effects of concomitant benzodiazepines on the safety and efficacy of esketamine nasal spray following first-dose treatment of patients in urgent need of symptom ...

Dong Jing Fu , MD, PhD;

Bettina Diekamp , PhD;

Janssen Cilag ;

Stephane Borentain , MD;

Robert Murray , MSc, MPH;

Kristin Heerlein , MD;

Qiaoyi Zhang , MD, PhD;

Cornelius S. , MD;

Maju Mathews , MD;

10/08/2020

Medication Preference for Injectable Versus Oral Antipsychotics in Patients With Schizophrenia: Results From a Patient-Reported Questionnaire From a Double-Blind Randomized Controlled Study

Introduction: Assessing factors that determine patients’ preferences for long-acting injectable (LAI) or oral antipsychotics could help reduce potential barriers to LAI use in schizophren...

Clifton Blackwood , MD;

Panna Sanga , MD;

Isaac Nuamah , PhD;

Arun K. Singh , MD, PhD, MCh, MNAMS;

Alexander Keenan , MA, MS, MD;

Srihari Gopal , MD;

Maju Mathews , MD;

11/22/2019

A Phase 3 Non-Inferiority Study Comparing Paliperidone Palmitate 1-Month vs 3-Month Long-Acting Injectables for Negative Symptom Improvement in Schizophrenia

Background: Negative symptoms of schizophrenia are predictors of long-term disability. Paliperidone palmitate 3-month formulation (PP3M) provides a sustained release of paliperidone, perm...

Edward S. Kim , MD, FACP, MBA;

Arun K. Singh , MD, PhD, MCh, MNAMS;

Katalin Pungor , PhD;

Maju Mathews , MD;

Jagadish Gogate , PhD;

Srihari Gopal , MD;

03/01/2019